Table 1.
Baseline characteristics.
| Variables | Mean ± SD or % |
|---|---|
| Age (y) | 67.7 ± 12.4 |
| Sex (male/female) | 14/6 |
| Body mass index (kg/m2) | 26.8 ± 4.9 |
| Alcohol (%) | 40 |
| Smoking (%) | 20 |
| Diabetes mellitus (%) | 40 |
| Dyslipidemia (%) | 85 |
| Previous cardiovascular disease (%) | 20 |
| Clinic blood pressure | |
| SBP (mmHg) | 151 ± 15 |
| DBP (mmHg) | 81 ± 8 |
| Glucose-lipid metabolism | |
| Fasting plasma glucose (mg/dL) | 130 ± 51 |
| Glycated hemoglobin (%) | 6.1 ± 0.8 |
| Total cholesterol (mg/dL) | 230 ± 33 |
| LDL-cholesterol (mg/dL) | 143 ± 27 |
| HDL-cholesterol (mg/dL) | 63 ± 21 |
| Triglycerides (mg/dL) | 195 ± 140 |
| Renal function | |
| Serum creatinine (mg/dL) | 1.04 ± 0.44 |
| eGFR (mL/min/1.73 m2) | 60.4 ± 25.8 |
| UACR (mg/g-Cr) | 1034 ± 1480 |
| Serum cystatin C (mg/L) | 1.30 ± 0.45 |
| Inflammatory and oxidative stress markers | |
| hs-CRP (mg/dL) | 0.18 ± 0.24 |
| Serum pentosidine (μg/mL) | 0.036 ± 0.013 |
| Medication | |
| Statin (%) | 30 |
| Calcium channel blockers (%) | 100 |
| RAS inhibitors (%) | 85 |
Values are means ± SD. SBP: systolic blood pressure; DBP: diastolic blood pressure; eGFR: estimated glomerular filtration rate; UACR: urine albumin-to-creatinine ratio; CRP: C-reactive protein; RAS: renin-angiotensin system.